Table 7.
Amino Acids Associated with Cervical hrHPV Infections
| Prevalent hrHPV | |||||||
|---|---|---|---|---|---|---|---|
| Number of Controls | Number of Cases | Odds Ratio (OR) | P value (Unadjusted) | P value Adjusted | |||
| ID | Carriers | Non-Carriers | Carriers | Non-Carriers | |||
| C_123_S | 49 | 343 | 6 | 119 | 0.38 | 0.012 | 0.012 |
| DQA1_230_M | 236 | 156 | 89 | 36 | 1.62 | 0.033 | 0.033 |
| DQA1_70_K | 45 | 347 | 24 | 101 | 1.84 | 0.034 | 0.034 |
| DQA1_75_H | 45 | 347 | 24 | 101 | 1.84 | 0.034 | 0.034 |
| DQA1_77_L | 45 | 347 | 24 | 101 | 1.84 | 0.034 | 0.034 |
| DQA1_75_R | 253 | 139 | 63 | 62 | 0.56 | 0.006 | 0.042 |
| DQA1_98_S | 170 | 222 | 37 | 88 | 0.55 | 0.006 | 0.012 |
| Persistent hrHPV | |||||||
| Number of Controls | Number of Cases | Odds Ratio (OR) | P value (Unadjusted) | P value Adjusted | |||
| ID | Carriers | Non-Carriers | ID | Carriers | |||
| DQB1_98_D | 130 | 225 | 31 | 20 | 2.66 | 0.001 | 0.003 |
| DQB1_99_I | 130 | 225 | 31 | 20 | 2.66 | 0.001 | 0.003 |
| DQB1_89_A | 107 | 248 | 26 | 25 | 2.4 | 0.004 | 0.012 |
| DQB1_103_K | 101 | 254 | 24 | 27 | 2.23 | 0.009 | 0.018 |
| DQB1_106_A | 101 | 254 | 24 | 27 | 2.23 | 0.009 | 0.018 |
| DQB1_60_S | 101 | 254 | 24 | 27 | 2.23 | 0.009 | 0.018 |
| DQB1_62_S | 101 | 254 | 24 | 27 | 2.23 | 0.009 | 0.018 |
| DQB1_69_I | 101 | 254 | 24 | 27 | 2.23 | 0.009 | 0.018 |
| DQB1_78_E | 101 | 254 | 24 | 27 | 2.23 | 0.009 | 0.018 |
| DQB1_84_L | 101 | 254 | 24 | 27 | 2.23 | 0.009 | 0.009 |
| DQB1_87_L | 101 | 254 | 24 | 27 | 2.23 | 0.009 | 0.009 |
| DQB1_62_H | 150 | 205 | 10 | 41 | 0.35 | 0.001 | 0.009 |
| DQB1_103_A | 125 | 230 | 8 | 43 | 0.36 | 0.006 | 0.012 |
| DQB1_46_L | 125 | 230 | 8 | 43 | 0.36 | 0.006 | 0.012 |
hrHPV = high-risk human papillomavirus; ID = HLA Gene_Position_Amino acid residue; A = Alanine; D = Aspartic acid; E = Glutamic acid; H = Histidine; I = Isoleucine; K = Lysine; L = Leucine; M = Methionine; R = Arginine; S = Serine